Last reviewed · How we verify

NCT00713349

A Randomized, Evaluator Blinded, Controlled Study of the Effect of Xenaderm® Ointment Vehicle Versus White Petrolatum on Healing of Induced Thermal Wounds

Completed Phase 2 Results posted Last updated 9 October 2013
What this trial tests

Phase 2 trial testing Xenaderm Vehicle in Wounds in 25 participants. Completed in 1 September 2008.

Timeline
1 June 2008
Primary endpoint
1 August 2008
1 September 2008

Quick facts

Lead sponsorHealthpoint
PhasePhase 2
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designsingle group
Maskingsingle
Primary purposetreatment
Enrollment25
Start date1 June 2008
Primary completion1 August 2008
Estimated completion1 September 2008
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

Healthpoint — full company profile →

Who can join

18 and older, any sex, with Wounds. Healthy volunteers can join.

What's being measured

Primary outcomes are the specific endpoints the trial is designed to prove or disprove.

Sponsor's own description

The objective of the study is to compare the healing of wounds induced by cryo-injury when treated with white petrolatum versus an ointment vehicle.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Wounds

Currently open trials in the same condition.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT00713349.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing